The results of the study predicted that higher serum levels of CCN1 are associated with an increased risk of osteoporosis in both UK Biobank and FinnGen datasets, while the former also projected a negative association between serum CCN2 and osteoporosis risk. The gene discussed is CCN1; the disease is osteoporosis.